Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival

Shaan Dudani(William Osler Health System), Daniel Y.C. Heng(University of Calgary)

JAMA Network Open

January 21, 2021

10.1001/jamanetworkopen.2020.21869

Cited by 295

Related Papers

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

|Nature Communications|2021|167

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma

|Cancer Immunology Research|2018|136

Integrative clinical and molecular characterization of translocation renal cell carcinoma

|Cell Reports|2022|115

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

|Cancers|2019|31

Table S1 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

|Unknown|2023|0